{
  "0": "the metabolism of [drug1] can be decreased when combined with [drug2].",
  "1": "[drug1] may decrease the excretion rate of [drug2] which could result in a higher serum level.",
  "2": "the risk or severity of adverse effects can be increased when [drug1] is combined with [drug2].",
  "3": "the metabolism of [drug1] can be increased when combined with [drug2].",
  "4": "the risk or severity of qtc prolongation can be increased when [drug1] is combined with [drug2].",
  "5": "the serum concentration of [drug1] can be increased when it is combined with [drug2].",
  "6": "the therapeutic efficacy of [drug1] can be decreased when used in combination with [drug2].",
  "7": "[drug1] may increase the central nervous system depressant (cns depressant) activities of [drug2].",
  "8": "the risk or severity of hypertension can be increased when [drug1] is combined with [drug2].",
  "9": "[drug1] may decrease the antihypertensive activities of [drug2].",
  "10": "[drug1] may increase the excretion rate of [drug2] which could result in a lower serum level and potentially a reduction in efficacy.",
  "11": "the serum concentration of [drug1] can be decreased when it is combined with [drug2].",
  "12": "the therapeutic efficacy of [drug1] can be increased when used in combination with [drug2].",
  "13": "[drug1] may increase the hypotensive activities of [drug2].",
  "14": "[drug1] may increase the arrhythmogenic activities of [drug2].",
  "15": "the risk or severity of hyperkalemia can be increased when [drug1] is combined with [drug2].",
  "16": "the risk or severity of hypoglycemia can be increased when [drug1] is combined with [drug2].",
  "17": "the excretion of [drug1] can be decreased when combined with [drug2].",
  "18": "the risk or severity of hyperglycemia can be increased when [drug1] is combined with [drug2].",
  "19": "[drug1] may increase the bradycardic activities of [drug2].",
  "20": "the risk or severity of [drug1] syndrome can be increased when [drug2] is combined with [drug1].",
  "21": "the risk or severity of bleeding can be increased when [drug1] is combined with [drug2].",
  "22": "the risk or severity of gastrointestinal irritation can be increased when [drug1] is combined with [drug2].",
  "23": "the risk or severity of hypotension can be increased when [drug1] is combined with [drug2].",
  "24": "[drug1] may increase the arrhythmogenic activities of [drug2].",
  "25": "the risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when [drug1] is combined with [drug2].",
  "26": "the risk or severity of cns depression can be increased when [drug1] is combined with [drug2].",
  "27": "[drug1] may increase the hypoglycemic activities of [drug2].",
  "28": "[drug1] may increase the orthostatic hypotensive activities of [drug2].",
  "29": "the risk or severity of bleeding and hemorrhage can be increased when [drug1] is combined with [drug2].",
  "30": "the risk or severity of tachycardia can be increased when [drug1] is combined with [drug2].",
  "31": "[drug1] may increase the neuromuscular blocking activities of [drug2].",
  "32": "the risk or severity of gastrointestinal bleeding can be increased when [drug1] is combined with [drug2].",
  "33": "[drug1] can cause a decrease in the absorption of [drug2] resulting in a reduced serum concentration and potentially a decrease in efficacy.",
  "34": "the risk or severity of hypokalemia can be increased when [drug1] is combined with [drug2].",
  "35": "[drug1] may increase the immunosuppressive activities of [drug2].",
  "36": "the risk or severity of renal failure, hyperkalemia, and hypertension can be increased when [drug1] is combined with [drug2].",
  "37": "[drug1] may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of [drug2].",
  "38": "[drug1] may increase the serotonergic activities of [drug2].",
  "39": "[drug1] may increase the qtc-prolonging activities of [drug2].",
  "40": "[drug1] may increase the hypertensive and vasoconstricting activities of [drug2].",
  "41": "[drug1] may increase the vasoconstricting activities of [drug2].",
  "42": "the protein binding of [drug1] can be decreased when combined with [drug2].",
  "43": "[drug1] may increase the hypertensive activities of [drug2].",
  "44": "[drug1] may increase the antihypertensive activities of [drug2].",
  "45": "[drug1] may increase the neuroexcitatory activities of [drug2].",
  "46": "the risk or severity of tendinopathy can be increased when [drug1] is combined with [drug2].",
  "47": "[drug1] may increase the anticoagulant activities of [drug2].",
  "48": "the risk or severity of edema formation can be increased when [drug1] is combined with [drug2].",
  "49": "[drug1] may decrease the hypoglycemic activities of [drug2].",
  "50": "the risk or severity of adverse effects can be increased when [drug1] is combined with [drug2].",
  "51": "[drug1] may increase the vasodilatory activities of [drug2].",
  "52": "the risk or severity of sedation can be increased when [drug1] is combined with [drug2].",
  "53": "[drug1] may increase the anticholinergic activities of [drug2].",
  "54": "[drug1] may increase the neurotoxic activities of [drug2].",
  "55": "[drug1] may increase the sedative activities of [drug2].",
  "56": "[drug1] may decrease the sedative activities of [drug2].",
  "57": "the risk or severity of nephrotoxicity can be increased when [drug1] is combined with [drug2].",
  "58": "the risk or severity of methemoglobinemia can be increased when [drug1] is combined with [drug2].",
  "59": "[drug1] may decrease the bronchodilatory activities of [drug2].",
  "60": "the risk or severity of hemorrhage can be increased when [drug1] is combined with [drug2].",
  "61": "[drug1] may increase the nephrotoxic activities of [drug2].",
  "62": "the risk or severity of hypotension and orthostatic hypotension can be increased when [drug1] is combined with [drug2].",
  "63": "the risk or severity of myelosuppression can be increased when [drug1] is combined with [drug2].",
  "64": "the risk or severity of hypotension and syncope can be increased when [drug1] is combined with [drug2].",
  "65": "[drug1] may increase the tachycardic activities of [drug2].",
  "66": "the risk or severity of seizure can be increased when [drug1] is combined with [drug2].",
  "67": "[drug1] may increase the hepatotoxic activities of [drug2].",
  "68": "the risk or severity of extrapyramidal symptoms can be increased when [drug1] is combined with [drug2].",
  "69": "the risk or severity of cardiac arrhythmia can be increased when [drug1] is combined with [drug2].",
  "70": "[drug1] may increase the hyperkalemic activities of [drug2].",
  "71": "the risk or severity of electrolyte imbalance can be increased when [drug1] is combined with [drug2].",
  "72": "the risk or severity of renal failure and hypertension can be increased when [drug1] is combined with [drug2].",
  "73": "the risk or severity of hypertension can be decreased when [drug1] is combined with [drug2].",
  "74": "the risk or severity of neutropenia can be increased when [drug1] is combined with [drug2].",
  "75": "the risk or severity of neutropenia and thrombocytopenia can be increased when [drug1] is combined with [drug2].",
  "76": "[drug1] may increase the vasopressor activities of [drug2].",
  "77": "[drug1] may decrease the excretion rate of [drug2] which could result in a higher serum level.",
  "78": "the risk or severity of qtc prolongation can be decreased when [drug1] is combined with [drug2].",
  "79": "the risk or severity of renal failure can be increased when [drug1] is combined with [drug2].",
  "80": "the risk or severity of tachycardia and drowsiness can be increased when [drug1] is combined with [drug2].",
  "81": "the risk or severity of hyponatremia can be increased when [drug1] is combined with [drug2].",
  "82": "[drug1] may increase the antiplatelet activities of [drug2].",
  "83": "[drug1] may increase the analgesic activities of [drug2].",
  "85": "the risk or severity of hypotension and cns depression can be increased when [drug1] is combined with [drug2].",
  "86": "the therapeutic efficacy of [drug1] can be decreased when used in combination with [drug2].",
  "87": "[drug1] can cause an increase in the absorption of [drug2] resulting in an increased serum concentration and potentially a worsening of adverse effects.",
  "88": "the risk or severity of hypokalemia can be increased when [drug1] is combined with [drug2].",
  "89": "[drug1] may decrease the stimulatory activities of [drug2].",
  "90": "the risk or severity of myopathy and weakness can be increased when [drug1] is combined with [drug2].",
  "91": "the risk or severity of hyperthermia and oligohydrosis can be increased when [drug1] is combined with [drug2].",
  "92": "[drug1] may increase the thrombogenic activities of [drug2].",
  "93": "the absorption of [drug1] can be decreased when combined with [drug2].",
  "94": "the risk or severity of sedation and somnolence can be increased when [drug1] is combined with [drug2].",
  "95": "the risk or severity of angioedema can be increased when [drug1] is combined with [drug2].",
  "96": "the risk or severity of renal failure, hypotension, and hyperkalemia can be increased when [drug1] is combined with [drug2].",
  "97": "the risk or severity of fluid retention can be increased when [drug1] is combined with [drug2].",
  "98": "the metabolism of [drug1] can be decreased when combined with [drug2]."
}